AlbertoP., SennH. J.: Hormonal therapy of renal carcinoma alone and in association with cytostatic drugs. Cancer, 33; 1226–1229 (1974).
2.
BloomH. J. G., DukesC. E., MitchleyB. C. V.: Hormone-dependent tumours of the kidney. Brit. J. Cancer, 17; 611–645 (1963).
3.
BloomH. J. G., RoeF. J. C., MitchleyB. C. V.: Sex hormones and renal neoplasia. Cancer, 20; 2118–2124 (1967).
4.
BloomH. J. G.: Hormone-induced and spontaneous regressione of metastatic renal cancer. Cancer, 32; 1066–1071 (1973).
5.
BojarH., DreyfurstR., BalzerK., StaibW., WittliffJ. L.: Oestrogen binding components in human renal cell carcinoma. J. Clin. Chem. Clin. Biochem., 14; 511–526 (1976).
6.
BracciU.: Intérêt de progesterone dans les metastases du cancer du rein. J. d'Urol., 79; 404 (1973).
7.
ConcolinoG., Di SilverioF., MarocchiA., BracciU.: Renal cancer steroid receptors: biochemical basis for endocrine therapy. Eur. Urol., 5; 90–93 (1979).
8.
De GiovanniG., BercovichE., MartelliA., SoliM., NanniP., GrilliS., GalliM. C.: Steroid hormone binding proteins in normal and neoplastic human kidney. IRCS Medical Science, Kidney and Urinary System, 6; 419 (1978).
9.
Di FronzoG., BertuzziA., RonchiE.: An improved criterion for the evaluation of estrogen receptor binding data in human breast cancer. Tumori, 64; 259–266 (1978).
10.
EORTC Breast Cancer Cooperative Group: Standards for the assessment of oestrogen receptors in human breast cancer. Eur. J. Cancer, 9; 379–381 (1973).
11.
FriedmanM. A.: Estradiol and progesterone receptors in human non breast malignant diseases. Clin. Res., 26; 435 (1978).
12.
GinsburgM., GreensteinB. D., MacluskyN. J., MorrisI. D., ThomasP. J.: An improved method for the study of high affinity steroid binding: oestradiol binding in brain and pituitary. Steroids, 23; 773–792 (1974).
13.
KirkmanH.: Estrogen induced tumours of tht kidney in the Syrian hamster. Nat. Cancer Inst. Monogr., 1; 1–59 (1959)
14.
MoralesA., KrulutaG., LottS.: Hormones in the treatment of metastatic renal cancer. J. Urol., 114; 692–693 (1975).
